rs138412741

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_012144.4(DNAI1):​c.1401+17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00916 in 1,613,914 control chromosomes in the GnomAD database, including 83 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0075 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0093 ( 76 hom. )

Consequence

DNAI1
NM_012144.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.374

Publications

1 publications found
Variant links:
Genes affected
DNAI1 (HGNC:2954): (dynein axonemal intermediate chain 1) This gene encodes a member of the dynein intermediate chain family. The encoded protein is part of the dynein complex in respiratory cilia. The inner- and outer-arm dyneins, which bridge between the doublet microtubules in axonemes, are the force-generating proteins responsible for the sliding movement in axonemes. The intermediate and light chains, thought to form the base of the dynein arm, help mediate attachment and may also participate in regulating dynein activity. Mutations in this gene result in abnormal ciliary ultrastructure and function associated with primary ciliary dyskinesia and Kartagener syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
DNAI1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 9-34512215-G-A is Benign according to our data. Variant chr9-34512215-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260200.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00747 (1138/152326) while in subpopulation NFE AF = 0.0107 (730/68030). AF 95% confidence interval is 0.0101. There are 7 homozygotes in GnomAd4. There are 588 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAI1NM_012144.4 linkc.1401+17G>A intron_variant Intron 14 of 19 ENST00000242317.9 NP_036276.1 Q9UI46-1A0A140VJI0
DNAI1NM_001281428.2 linkc.1413+17G>A intron_variant Intron 14 of 19 NP_001268357.1 Q9UI46A0A087WWV9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAI1ENST00000242317.9 linkc.1401+17G>A intron_variant Intron 14 of 19 1 NM_012144.4 ENSP00000242317.4 Q9UI46-1
DNAI1ENST00000614641.4 linkc.1413+17G>A intron_variant Intron 14 of 19 5 ENSP00000480538.1 A0A087WWV9
DNAI1ENST00000470169.5 linkn.336+17G>A intron_variant Intron 2 of 5 5 ENSP00000434296.1 H0YDT9

Frequencies

GnomAD3 genomes
AF:
0.00748
AC:
1138
AN:
152208
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.0205
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0107
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00822
AC:
2067
AN:
251490
AF XY:
0.00826
show subpopulations
Gnomad AFR exome
AF:
0.00148
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.00645
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0213
Gnomad NFE exome
AF:
0.0117
Gnomad OTH exome
AF:
0.00749
GnomAD4 exome
AF:
0.00934
AC:
13644
AN:
1461588
Hom.:
76
Cov.:
32
AF XY:
0.00929
AC XY:
6752
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.00161
AC:
54
AN:
33474
American (AMR)
AF:
0.00183
AC:
82
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00739
AC:
193
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00347
AC:
299
AN:
86250
European-Finnish (FIN)
AF:
0.0217
AC:
1161
AN:
53420
Middle Eastern (MID)
AF:
0.00451
AC:
26
AN:
5768
European-Non Finnish (NFE)
AF:
0.0103
AC:
11402
AN:
1111732
Other (OTH)
AF:
0.00707
AC:
427
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
834
1669
2503
3338
4172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00747
AC:
1138
AN:
152326
Hom.:
7
Cov.:
32
AF XY:
0.00789
AC XY:
588
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00168
AC:
70
AN:
41564
American (AMR)
AF:
0.00372
AC:
57
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00332
AC:
16
AN:
4826
European-Finnish (FIN)
AF:
0.0205
AC:
218
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0107
AC:
730
AN:
68030
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
65
129
194
258
323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00896
Hom.:
2
Bravo
AF:
0.00598
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 24, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kartagener syndrome Benign:1
Oct 11, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
7.1
DANN
Benign
0.80
PhyloP100
0.37
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138412741; hg19: chr9-34512213; API